Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,351
datasets available to search
ShareScore release 0.9.0
Dataset results
1,351 results for “Intermediates”
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate
ClinicalTrials.gov study NCT03222128. IPD Sharing: NO. Countries: 1. Publications: 10.
Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
ClinicalTrials.gov study NCT03988842. IPD Sharing: NO. Countries: 1. Publications: 28.
Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma
ClinicalTrials.gov study NCT00607113. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT04688931. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Study of LBH589 for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00939159. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
ClinicalTrials.gov study NCT01736683. IPD Sharing: YES. Countries: 2. Publications: 1.
Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness
ClinicalTrials.gov study NCT07339943. IPD Sharing: YES. Countries: 1. Publications: 18.
A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02158936. IPD Sharing: Not stated. Countries: 30. Publications: 1.
A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate
ClinicalTrials.gov study NCT00855218. IPD Sharing: Not stated. Countries: 13. Publications: 1.
eXtended Antibiotic Prophylaxis for Intermediate- and High-risk Glands After Pancreatoduodenectomy to Reduce CR-POPF
ClinicalTrials.gov study NCT05753735. IPD Sharing: YES. Countries: 1. Publications: 2.
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT03558503. IPD Sharing: NO. Countries: 2. Publications: 3.
Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
ClinicalTrials.gov study NCT04367831. IPD Sharing: NO. Countries: 1. Publications: 3.
Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy
ClinicalTrials.gov study NCT03889756. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT00712582. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT02603887. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-esse
ClinicalTrials.gov study NCT03952039. IPD Sharing: YES. Countries: 16. Publications: 1.
Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer
ClinicalTrials.gov study NCT02923180. IPD Sharing: NO. Countries: 1. Publications: 1.
Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients
ClinicalTrials.gov study NCT04401293. IPD Sharing: NO. Countries: 1. Publications: 5.
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
ClinicalTrials.gov study NCT02567435. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients
ClinicalTrials.gov study NCT02919111. IPD Sharing: NO. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.